Literature DB >> 29305113

Developing a Postpartum Depression Screening and Referral Procedure in Pediatric Primary Care.

Julee Waldrop, Alasia Ledford, Leslie Chandler Perry, Linda S Beeber.   

Abstract

INTRODUCTION: Postpartum depression affects approximately 10% to 20% of mothers and impairs a mother's ability to engage with her child at an emotional and cognitive level, placing the child at greater risk for impaired development. Early diagnosis and management can reduce its negative impacts. Despite mothers being receptive to screening, screening rates are less than 50%.
METHODS: This article provides an appraisal of the current state of the evidence on implementing screening for postpartum depression in pediatric primary care. It describes how to use a clinical decision support algorithm for screening and follow-up and the process of developing an accompanying referral/resource list.
RESULTS: Evidence supports the use of clinical decision support algorithm and the need for having local resources and referrals available at the point of care. DISCUSSION: Screening for postpartum depression in the pediatric primary care setting is feasible and can be adapted to the local setting.
Copyright © 2017 National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Postpartum depression; algothrim; decision support; primary care pediatrics; screening

Mesh:

Year:  2018        PMID: 29305113     DOI: 10.1016/j.pedhc.2017.11.002

Source DB:  PubMed          Journal:  J Pediatr Health Care        ISSN: 0891-5245            Impact factor:   1.812


  2 in total

1.  Elevating mothers' voices: recommendations for improved patient-centered postpartum.

Authors:  Sarah Verbiest; Kristin Tully; Monica Simpson; Alison Stuebe
Journal:  J Behav Med       Date:  2018-08-09

2.  A Refined Model of Stress-Diathesis Relationships in Mothers With Significant Depressive Symptom Severity.

Authors:  Yui Matsuda; Todd A Schwartz; YunKyung Chang; Linda S Beeber
Journal:  J Am Psychiatr Nurses Assoc       Date:  2019-10-03       Impact factor: 2.385

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.